Morgan Stanley Reiterates Overweight on Humana, Maintains $637 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Michael Ha has reiterated an Overweight rating on Humana (NYSE:HUM) and maintained a price target of $637.
July 14, 2023 | 2:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has reiterated an Overweight rating on Humana and maintained a price target of $637.
The reiteration of an Overweight rating by Morgan Stanley indicates a positive outlook for Humana. The maintained price target of $637 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100